Adoptive cell therapies based on chimeric antigen receptor (CAR)-T cells and tumor-infiltrating lymphocytes (TILs) have transformed cancer treatment, particularly for blood cancers and some solid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results